MoneyWorks4Me

Ambalal Sarabhai Enterprises informs about change in directorate

30 Nov 2019 Evaluate

In terms of the regulation 30 of SEBI (LODR) regulations, 2015, Ambalal Sarabhai Enterprises has informed that A.H. Parekh who is working as a Whole-Time Director of the Company, will be ceased to be a Whole-Time Director after closure of office hours on 30.11.2019 and thereafter from 1st, December 2019 continue on the Board as a Non-Executive Director.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..